Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia. Kovy P, Orfi Z, Bors A, Kozma A, et al. PLoS One 2021;16:e0253386.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kovy P, Orfi Z, Bors A, Kozma A, et al. Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia. PLoS One 2021;16:e0253386.
PMID: 34153064